The objective of this study was to prove the bioequivalence of Ramipril 10 mg capsules under
- No clinically significant abnormal findings on the physical examination, medical
history, or clinical laboratory results during screening
- Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme
altering drugs. History of allergic or adverse response to Ramipril or any comparable
or similar product.